Peter Linneman
Known title: DirectorCIK: 0001170994
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
KBRA rates GCAT trust; AG Mortgage IT reports Q2 earnings. KBRA assigned preliminary ratings to the GCAT 2026-CES1 Trust, a move that affects the broader mortgage-backed securities market. Separately, AG Mortgage IT released its Q2 2026 earnings call transcript. These events provide context for the mortgage sector, though they do not directly report on TPG Mortgage Investment Trust's specific financial results.
Transaction History
| REG | ▲ Buy | Grant | 318 | — | 8/7/2026 | View on chart |
| REG | ▲ Buy | Option Exercise | 1,736 | — | 5/11/2026 | View on chart |
| REG | ▲ Buy | Option Exercise | 71 | — | 5/11/2026 | View on chart |
| REG | ▲ Buy | Grant | 336 | — | 5/6/2026 | View on chart |
| REG | ▲ Buy | Grant | 357 | — | 2/4/2026 | View on chart |
| REG | ▲ Buy | Grant | 351 | — | 11/6/2025 | View on chart |
| REG | ▲ Buy | Grant | 350 | — | 8/8/2025 | View on chart |
| REG | ▲ Buy | Option Exercise | 85 | — | 5/5/2025 | View on chart |
| REG | ▲ Buy | Option Exercise | 2,115 | — | 5/5/2025 | View on chart |
| REG | ▲ Buy | Grant | 343 | — | 5/5/2025 | View on chart |
| MITT | ▲ Buy | Grant | 2,747 | $0 | 4/1/2025 | View on chart |
| REG | ▲ Buy | Grant | 342 | — | 2/10/2025 | View on chart |
| MITT | ▲ Buy | Grant | 2,985 | $0 | 1/2/2025 | View on chart |
| REG | ▲ Buy | Grant | 361 | — | 11/12/2024 | View on chart |
| MITT | ▲ Buy | Grant | 2,638 | $0 | 10/1/2024 | View on chart |
| REG | ▲ Buy | Grant | 417 | — | 8/5/2024 | View on chart |
| MITT | ▲ Buy | Grant | 3,021 | $0 | 7/1/2024 | View on chart |
| REG | ▲ Buy | Grant | 404 | — | 5/7/2024 | View on chart |
| REG | ▲ Buy | Option Exercise | 2,096 | — | 5/3/2024 | View on chart |
| REG | ▲ Buy | Option Exercise | 67 | — | 5/3/2024 | View on chart |
| MITT | ▲ Buy | Grant | 3,311 | $0 | 4/1/2024 | View on chart |
| REG | ▲ Buy | Grant | 404 | — | 2/12/2024 | View on chart |
| MITT | ▲ Buy | Grant | 3,164 | $0 | 1/2/2024 | View on chart |
| REG | ▲ Buy | Grant | 396 | — | 11/1/2023 | View on chart |
| MITT | ▲ Buy | Grant | 3,597 | $0 | 10/2/2023 | View on chart |
| REG | ▲ Buy | Grant | 420 | — | 8/1/2023 | View on chart |
| MITT | ▲ Buy | Grant | 3,257 | $0 | 7/3/2023 | View on chart |
| REG | ▲ Buy | Grant | 397 | — | 5/4/2023 | View on chart |
| REG | ▲ Buy | Option Exercise | 79 | — | 5/3/2023 | View on chart |
| REG | ▲ Buy | Option Exercise | 1,817 | — | 5/3/2023 | View on chart |
| MITT | ▲ Buy | Grant | 3,508 | $0 | 4/3/2023 | View on chart |
| REG | ▲ Buy | Grant | 407 | — | 2/8/2023 | View on chart |
| MITT | ▲ Buy | Grant | 3,752 | $20K | 1/3/2023 | View on chart |
| REG | ▲ Buy | Grant | 409 | — | 11/3/2022 | View on chart |
| MITT | ▲ Buy | Grant | 4,739 | $0 | 10/3/2022 | View on chart |
| REG | ▲ Buy | Grant | 377 | — | 8/5/2022 | View on chart |
| MITT | ▲ Buy | Grant | 2,980 | $0 | 7/1/2022 | View on chart |
| REG | ▲ Buy | Option Exercise | 2,000 | — | 5/9/2022 | View on chart |
| REG | ▲ Buy | Option Exercise | 71 | — | 5/9/2022 | View on chart |
| REG | ▲ Buy | Grant | 357 | — | 4/29/2022 | View on chart |
| MITT | ▲ Buy | Grant | 2,178 | $0 | 4/1/2022 | View on chart |
| REG | ▲ Buy | Grant | 346 | — | 2/11/2022 | View on chart |
| MITT | ▲ Buy | Grant | 1,945 | $0 | 1/3/2022 | View on chart |
| REG | ▲ Buy | Grant | 377 | — | 10/29/2021 | View on chart |
| MITT | ▲ Buy | Grant | 1,765 | $0 | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Regency Centers Faces Analyst Adjustments Amid Rate Concerns
Regency Centers is navigating a challenging environment as broader REITs face pressure from high interest rates. Recent analyst actions include Truist assuming coverage at a Buy rating and Barclays lowering its price target to $85 while maintaining an Overweight stance. The company is also preparing for its third-quarter 2026 earnings call, with the stock currently trading near its 52-week low.
Regency Centers Faces Analyst Adjustments Amid Rate Concerns. Regency Centers is navigating a challenging environment as broader REITs face pressure from high interest rates. Recent analyst actions include Truist assuming coverage at a Buy rating and Barclays lowering its price target to $85 while maintaining an Overweight stance. The company is also preparing for its third-quarter 2026 earnings call, with the stock currently trading near its 52-week low.